##gff-version 3
##sequence-region Q92781 1 318
Q92781	UniProtKB	Signal peptide	1	23	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q92781	UniProtKB	Chain	24	318	.	.	.	ID=PRO_0000054758;Note=11-cis retinol dehydrogenase	
Q92781	UniProtKB	Nucleotide binding	32	56	.	.	.	Note=NADP;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q92781	UniProtKB	Active site	175	175	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q92781	UniProtKB	Binding site	163	163	.	.	.	Note=Substrate;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q92781	UniProtKB	Glycosylation	160	160	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q92781	UniProtKB	Natural variant	21	21	.	.	.	ID=VAR_052321;Note=R->Q;Dbxref=dbSNP:rs3138143	
Q92781	UniProtKB	Natural variant	33	33	.	.	.	ID=VAR_009272;Note=I->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10369264;Dbxref=dbSNP:rs62638195,PMID:10369264	
Q92781	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_016814;Note=In FALBI%3B decreased stability. G->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11053295,ECO:0000269|PubMed:11675386;Dbxref=dbSNP:rs759359491,PMID:11053295,PMID:11675386	
Q92781	UniProtKB	Natural variant	70	70	.	.	.	ID=VAR_052322;Note=R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9115228;Dbxref=dbSNP:rs1058635,PMID:9115228	
Q92781	UniProtKB	Natural variant	73	73	.	.	.	ID=VAR_009273;Note=In FALBI%3B decreased stability%3B loss of enzymatic activity%3B accumulates in the perinuclear region. S->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10369264,ECO:0000269|PubMed:11675386;Dbxref=dbSNP:rs62638185,PMID:10369264,PMID:11675386	
Q92781	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_068716;Note=In FALBI%3B decreased stability. L->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11675386;Dbxref=dbSNP:rs765993603,PMID:11675386	
Q92781	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_016815;Note=In FALBI%3B associated with macular dystrophy. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11053295,ECO:0000269|PubMed:12788147;Dbxref=PMID:11053295,PMID:12788147	
Q92781	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_068717;Note=In FALBI%3B decreased stability. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11675386;Dbxref=dbSNP:rs377029071,PMID:11675386	
Q92781	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_016816;Note=In FALBI. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11053295;Dbxref=dbSNP:rs62638187,PMID:11053295	
Q92781	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_068718;Note=In FALBI%3B decreased stability. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11675386;Dbxref=dbSNP:rs104894374,PMID:11675386	
Q92781	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_016817;Note=In FALBI. V->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12967826;Dbxref=dbSNP:rs755168439,PMID:12967826	
Q92781	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_075309;Note=In FALBI. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25820994;Dbxref=dbSNP:rs758411232,PMID:25820994	
Q92781	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_016818;Note=In FALBI. V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11078852;Dbxref=dbSNP:rs104894373,PMID:11078852	
Q92781	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_009274;Note=In FALBI%3B decreased stability%3B loss of enzymatic activity%3B accumulates in the perinuclear region. G->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10369264,ECO:0000269|PubMed:10617778,ECO:0000269|PubMed:11675386;Dbxref=dbSNP:rs62638191,PMID:10369264,PMID:10617778,PMID:11675386	
Q92781	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_068719;Note=In FALBI%3B decreased stability. V->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11053296,ECO:0000269|PubMed:11675386;Dbxref=PMID:11053296,PMID:11675386	
Q92781	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_016819;Note=In FALBI. C->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11470705;Dbxref=PMID:11470705	
Q92781	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_016820;Note=In FALBI%3B decreased stability%3B loss of enzymatic activity. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10617778,ECO:0000269|PubMed:11053295,ECO:0000269|PubMed:11078852,ECO:0000269|PubMed:11675386;Dbxref=dbSNP:rs62638193,PMID:10617778,PMID:11053295,PMID:11078852,PMID:11675386	
Q92781	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_016821;Note=In FALBI. Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11053295;Dbxref=dbSNP:rs62638194,PMID:11053295	
Q92781	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_016822;Note=In FALBI%3B no effect on enzymatic activity%3B accumulates in the perinuclear region. A->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10617778,ECO:0000269|PubMed:11675386;Dbxref=dbSNP:rs111033593,PMID:10617778,PMID:11675386	
Q92781	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_016823;Note=In FALBI%3B loss of enzymatic activity%3B accumulates in the perinuclear region. L->EV;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11053296,ECO:0000269|PubMed:11675386;Dbxref=PMID:11053296,PMID:11675386	
Q92781	UniProtKB	Sequence conflict	30	30	.	.	.	Note=F->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q92781	UniProtKB	Sequence conflict	51	52	.	.	.	Note=RG->KS;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q92781	UniProtKB	Sequence conflict	75	77	.	.	.	Note=RLH->GFN;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q92781	UniProtKB	Sequence conflict	89	89	.	.	.	Note=V->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q92781	UniProtKB	Sequence conflict	200	200	.	.	.	Note=V->E;Ontology_term=ECO:0000305;evidence=ECO:0000305	
